Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Quintrex M Tranexamic Acid and Mefenamic Acid Tablet
Quintrex M, provided by Lexaro Healthcare, combines Tranexamic Acid and Mefenamic Acid in a tablet formulation. Each tablet is designed to provide high-quality, effective treatment for conditions involving heavy menstrual bleeding and associated pain.
Uses of Quintrex M Tranexamic Acid and Mefenamic Acid Tablet
Quintrex M is primarily prescribed for the treatment of heavy menstrual bleeding (menorrhagia) and the associated pain and discomfort. It helps to reduce excessive bleeding and alleviates menstrual pain, improving the quality of life for patients.
Benefits of Quintrex M Tranexamic Acid and Mefenamic Acid Tablet
Effective in reducing heavy menstrual bleeding.
Provides relief from menstrual pain and discomfort.
Convenient dosing regimen for improved patient compliance.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Quintrex M Tranexamic Acid and Mefenamic Acid Tablet
Tranexamic Acid works by inhibiting plasminogen activation and the subsequent conversion of plasminogen to plasmin, a molecule involved in the breakdown of fibrin clots. This action helps to reduce excessive bleeding. Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes, reducing the production of prostaglandins that cause pain and inflammation. Together, they provide effective relief from heavy menstrual bleeding and associated pain.